2ax0: Difference between revisions

Revision as of 12:26, 29 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:2ax0.png

Template:STRUCTURE 2ax0

Hepatitis C Virus NS5b RNA Polymerase in complex with a covalent inhibitor (5x)Hepatitis C Virus NS5b RNA Polymerase in complex with a covalent inhibitor (5x)

Template:ABSTRACT PUBMED 16451069

About this StructureAbout this Structure

2AX0 is a Single protein structure of sequence from Hepatitis c virus. Full crystallographic information is available from OCA.

ReferenceReference

SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase., Powers JP, Piper DE, Li Y, Mayorga V, Anzola J, Chen JM, Jaen JC, Lee G, Liu J, Peterson MG, Tonn GR, Ye Q, Walker NP, Wang Z, J Med Chem. 2006 Feb 9;49(3):1034-46. PMID:16451069

Page seeded by OCA on Tue Jul 29 12:26:56 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:2ax0.gif|left|200px]]
+{{Seed}}
+[[Image:2ax0.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2ax0|  PDB=2ax0  |  SCENE=  }}
-'''Hepatitis C Virus NS5b RNA Polymerase in complex with a covalent inhibitor (5x)'''
+===Hepatitis C Virus NS5b RNA Polymerase in complex with a covalent inhibitor (5x)===
-==Overview==
+<!--
-Novel non-nucleoside inhibitors of the HCV RNA polymerase (NS5b) with sub-micromolar biochemical potency have been identified which are selective for the inhibition of HCV NS5b over other polymerases. The structures of the complexes formed between several of these inhibitors and HCV NS5b were determined by X-ray crystallography, and the inhibitors were found to bind in an allosteric binding site separate from the active site. Structure-activity relationships and structural studies have identified the mechanism of action for compounds in this series, several of which possess drug-like properties, as unique, reversible, covalent inhibitors of HCV NS5b.
+The line below this paragraph, {{ABSTRACT_PUBMED_16451069}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 16451069 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_16451069}}
 ==About this Structure==
@@ Line 43: / Line 47: @@
 [[Category: Polymerase]]
 [[Category: Thumb]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 19:34:30 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 12:26:56 2008''